Global circRNA-LNP Formulation Market Growth 2026-2032
Description
The global circRNA-LNP Formulation market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Circular RNAs (circRNAs) are covalently closed RNA molecules generated mainly from pre-mRNA back-splicing, and have also been found to function as mRNAs to direct protein synthesis inside cells. As a new generation of therapeutic mRNAs, circRNAs may address some of the limitations of linear mRNA including increased stability, reduced immunogenicity, and tissue/cell-specific translation. Therefore, translatable circRNAs are able to produce more therapeutic protein inside the body than conventional mRNA, with the potential to engineer cells, replace damaged proteins, or add new beneficial proteins for patients with serious diseases.LNPs have been proven to be an effective drug delivery system for RNA therapeutics which can be easily degraded in vivo. The lipid layer can fuse with the cell membrane, allowing the encapsulated RNA to enter the cell and exert its therapeutic effect. They also protect therapeutic agents from degradation and improve their bioavailability.
United States market for circRNA-LNP Formulation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for circRNA-LNP Formulation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for circRNA-LNP Formulation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key circRNA-LNP Formulation players cover Orna Therapeutics, GenScript, Creative Biogene, Catalent, Creative Biolabs, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “circRNA-LNP Formulation Industry Forecast” looks at past sales and reviews total world circRNA-LNP Formulation sales in 2025, providing a comprehensive analysis by region and market sector of projected circRNA-LNP Formulation sales for 2026 through 2032. With circRNA-LNP Formulation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world circRNA-LNP Formulation industry.
This Insight Report provides a comprehensive analysis of the global circRNA-LNP Formulation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on circRNA-LNP Formulation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global circRNA-LNP Formulation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for circRNA-LNP Formulation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global circRNA-LNP Formulation.
This report presents a comprehensive overview, market shares, and growth opportunities of circRNA-LNP Formulation market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Premade
Customized
Segmentation by Application:
Scientific Research
Pharmaceuticals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Orna Therapeutics
GenScript
Creative Biogene
Catalent
Creative Biolabs
VectorBuilder
Guangzhou Geneseed Biotech. Co., Ltd.
Porton Pharma Solutions, Ltd
Recipharm AB
Precigenome LLC
Key Questions Addressed in this Report
What is the 10-year outlook for the global circRNA-LNP Formulation market?
What factors are driving circRNA-LNP Formulation market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do circRNA-LNP Formulation market opportunities vary by end market size?
How does circRNA-LNP Formulation break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Circular RNAs (circRNAs) are covalently closed RNA molecules generated mainly from pre-mRNA back-splicing, and have also been found to function as mRNAs to direct protein synthesis inside cells. As a new generation of therapeutic mRNAs, circRNAs may address some of the limitations of linear mRNA including increased stability, reduced immunogenicity, and tissue/cell-specific translation. Therefore, translatable circRNAs are able to produce more therapeutic protein inside the body than conventional mRNA, with the potential to engineer cells, replace damaged proteins, or add new beneficial proteins for patients with serious diseases.LNPs have been proven to be an effective drug delivery system for RNA therapeutics which can be easily degraded in vivo. The lipid layer can fuse with the cell membrane, allowing the encapsulated RNA to enter the cell and exert its therapeutic effect. They also protect therapeutic agents from degradation and improve their bioavailability.
United States market for circRNA-LNP Formulation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for circRNA-LNP Formulation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for circRNA-LNP Formulation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key circRNA-LNP Formulation players cover Orna Therapeutics, GenScript, Creative Biogene, Catalent, Creative Biolabs, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “circRNA-LNP Formulation Industry Forecast” looks at past sales and reviews total world circRNA-LNP Formulation sales in 2025, providing a comprehensive analysis by region and market sector of projected circRNA-LNP Formulation sales for 2026 through 2032. With circRNA-LNP Formulation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world circRNA-LNP Formulation industry.
This Insight Report provides a comprehensive analysis of the global circRNA-LNP Formulation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on circRNA-LNP Formulation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global circRNA-LNP Formulation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for circRNA-LNP Formulation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global circRNA-LNP Formulation.
This report presents a comprehensive overview, market shares, and growth opportunities of circRNA-LNP Formulation market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Premade
Customized
Segmentation by Application:
Scientific Research
Pharmaceuticals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Orna Therapeutics
GenScript
Creative Biogene
Catalent
Creative Biolabs
VectorBuilder
Guangzhou Geneseed Biotech. Co., Ltd.
Porton Pharma Solutions, Ltd
Recipharm AB
Precigenome LLC
Key Questions Addressed in this Report
What is the 10-year outlook for the global circRNA-LNP Formulation market?
What factors are driving circRNA-LNP Formulation market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do circRNA-LNP Formulation market opportunities vary by end market size?
How does circRNA-LNP Formulation break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
100 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for circRNA-LNP Formulation by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for circRNA-LNP Formulation by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
